CompoAtlas

Diosmin 300 mg + Hesperidin 33 mg

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
5-Hydroxy-2-(3-hydroxy-4-méthoxyphényl)-7-(O6-alpha-L-rhamnopyranosyl-bêta-D-glucopyranosyloxy)chromen-4-one

Source : Citrus sinensis - Écorce de fruit

300 mgNot calculated
5-Hydroxy-2-(3-hydroxy-4-méthoxyphényl)-7-(O6-alpha-L-rhamnopyranosyl-bêta-D-glucopyranosyloxy)chromen-4-one

Source : Bioflavonoïdes d'agrumes

300 mgNot calculated
(2S)-7-[[6-O-(6-Déoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-méthoxyphényl)-4H-1-benzopyrane-4-one

Source : Citrus sinensis - fruit

33 mgNot calculated
(2S)-7-[[6-O-(6-Déoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-méthoxyphényl)-4H-1-benzopyrane-4-one

Source : Bioflavonoïdes d'agrumes

33 mgNot calculated

Non-medicinal ingredients

Stéarate de magnésium, Dioxyde de silicium colloïdal, Gel de silice colloïdal, Polacriline potassium, Dioxyde de titane, Lauryl sulfate de sodium, Benzoate de sodium, Oxyde de fer (Fe2O3), Phosphate de calcium, dibasique, Talc, Oxyde de fer jaune, Gélatine, Poly(éthylène glycol)

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Comprimé3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps relieve symptoms of non-complicated chronic venous insufficiency (CVI) such as sensation of swelling, varicose veins, feeling of heaviness, pain, tiredness and itching.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Other names
Cell DioHesp, Cell DiosHesp 333 mg, Cell Diosmin-Hesperidin 333 mg, Diosmin and Hesperidin 333 mg
Licence holder
CellChem Pharmaceuticals Inc.
NPN or DIN-HM
80127695
Status
Active licence
Licence date
31 October 2023
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Générale (non traditionelle)

Source

Official Health Canada record, licence 80127695

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Diosmin 300 mg + Hesperidin 33 mg (CellChem Pharmaceuticals Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80127695-diosmin-300-mg-hesperidin-33-mg, updated 31 October 2023.

Enter to analyse, Shift+Enter for a new line